The Company has informed the stock exchange regarding receipt of In-Principle approval for issue of shares on preferential basis.

Date: 13th October, 2026 The Manager, BSE SME Platform Department of Corporate Services, 25th Floor P.J. Towers, Dalal Street Fort, Mumbai - 400 001 Scrip code: 542934 SUB: Disclosure under regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 on receipt of In-Principle Approval for Preferential Issue: Pursuant to Reg. 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 (“LODR”) the stock exchange i.e. BSE Limited (‘BSE’) has issued In-Principle approval letter vide Ref: LOD/PREF/DA/FIP/931/2026-27 dated 12th October, 2026 for issue of 66,00,000 convertible warrants into 66,00,000 Equity shares to be issued at price not less than Rs. 44 to Promoter and non-promoters on a preferential basis. The In-principle approval letter received from the stock exchange i.e. BSE limited is enclosed herewith. Thanking you, Yours faithfully, For Chandra Bhagat Pharma Limited Hemant Chandravadan Bhagat Managing Director DIN: 00233530 The Power of Vibrance LOD/PREF/DA/FIP/931/2026-27 October 12, 2026 The Company Secretary, Chandra Bhagat Pharma Limited 323-F, Bhagat Bhuvan, Dr Ambedkar Road, Matunga (East), Mumb- a400i019 . Re: ‘In-principle’ approval under Regulation 28(1) of the SEBI (Listing Obligationansd Disclosure Requirements), Regulations, 2015, Dear Sir/Madam, We refer to your application seeking our “In-principal approval for the issue of 66,00,000 warrants convertible into 66,00,000 equity shares of Rs. 10/- each at price not less than Rs. 44/- each to promoters and non- promoters on preferential basis”. The Exchange hereby grants its ‘in-principle’ approval for the aforesaid issue. This ‘in-principle’ approval should not be construed as our approval for listing of aforesaid security, and you are required to duly and separately comply with the requirements in respect thereof. You are advised to ensure that the issue and allotment of securities is strictly in accordance with the provisions of the Companies Act, 2013, Securities Contracts (Regulation) Act, 1956, the Securities and Exchange Board of India Act, 1992, the Depositories Act, 1996 including the Rules, Regulations, Guidelines, etc. made there under, Chapter V of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations), the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (LODR Regulations) and the Listing Agreement signed with us. In addition, you shall also obtain such statutoraynd other approvals as are required for the purpose. Further, the company is advised to strengthen internal controls (to monitor trades being executed by the proposed allottees in the scrip of the company) before allotment of securities in order to avoid any non-compliances in respect of trades being executed by the allottees in contravention to provisions of ChapterV of SEBI (ICDR) Regulations. In this regard, a) Company is advised to obtain an undertaking from the allottee(s) confirming that they shall not do intra-day trading in the scrip of the companyo r any sale in the scrip of the companyti ll the allotment date of the security as required under SEBI (ICDR) Regulations. Registered Office: BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai 400001, India. T: +91 22 2272 1234/33 | E: corp.comm@bseindia.com www.bseindia.com | Corporate Identity Number : L67120MH2005PLCI55188 The Power of Vibrance b) The company may note that the responsibility/onus is solelyon the Issuer company to verify the above (a) and ensure compliance with applicable provisions including Regulation 167(6) of SEBIICDR regulations, 2018. ) The company may also note that any non-compliances, if observed by the exchanges post the undertaking and verification by the Issuer company may impact the listing of such shares. On allotment of securities pursuant to this ‘in principle’ approval you are required to make a listing application without delay, with applicable fees, in terms of Regulation 14 of the LODR Regulations and comply with the post issue formalities. Listing application and the checklist for post issue listing formalities can be downloaded from the link: hjmflmeQQeMa.gm&an;/abQuI/downlpMpx. Further, it should be noted by Depositories and the Company that in case of allotment of Convertible Securities, there would be automatic release of excess lock-in period of Pre-Preferential Holding of allottees by Depositories in compliance with SEBI(ICDR) Regulations,2018 without requirement of any NOC by the Exchange. In addition to above, the company should note that as per Schedule XIX - Para (2) of ICDR Regulations and as specified in SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, “the issuer or the issuing company, as the case may be, shall, make an application for listing, within twenty daysfrom the date of allotment, to one or more recognized stock exchange(s)” along with the documents specified by stock exchange(s) from time to time. Any Non-compliance with the above requirement will attract, the fine as mentioned in SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21,2023. The Exchange reserves its right to withdraw this ‘in-principle’ approval at any stage if the information submitted to the Exchange is found to be incomplete/ incorrect/ misleading/ false or if it contravenes any Rules, Bye-laws and Regulations of the Exchange, LODR Regulations, ICDR Regulations and Guidelines/ Regulations issued by any statutory authorities etc. Yours faithfully, itinkunar Pujari Dhananjay Apte Assistant Vice President Deputy Manager